Mirae Asset Securities (Usa) Inc. Tg Therapeutics, Inc. Transaction History
Mirae Asset Securities (Usa) Inc.
- $3.27 Trillion
- Q2 2025
A detailed history of Mirae Asset Securities (Usa) Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Securities (Usa) Inc. holds 100,260 shares of TGTX stock, worth $2.78 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
100,260
Previous 180,752
44.53%
Holding current value
$2.78 Million
Previous $7.13 Billion
49.37%
% of portfolio
0.11%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
413Shares Held
87.9MCall Options Held
2.34MPut Options Held
1.93M-
Vanguard Group Inc Valley Forge, PA15.6MShares$432 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$315 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$206 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$90.9 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$78.9 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.02B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...